Thrombosis prophylaxis in orthopaedic surgery: Considerations and uncertainties;Tromboseprofylaxe in de orthopedische chirurgie: Inzichten en onzekerheden

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 38, 2003, Pages 1842-1847

  Ettema, H B ^a   Hoppener, M R ^a   Buller H R ^b   Henny, Ch P ^b   Verheyen, C C P M ^a  

^a ISALA HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ANTICOAGULANT THERAPY; CLINICAL TRIAL; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HUMAN; LEG COMPRESSION; MAJOR CLINICAL STUDY; META ANALYSIS; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; REVIEW; THROMBOEMBOLISM; THROMBOSIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LEG; ORTHOPEDICS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TIME FACTORS; VENOUS THROMBOSIS;

EID: 0141621825     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Schonenberg D, Meeteren M van, Nelissen RGHH, Horst-Bruinsma IE van der, Pöll RG, Nurmohamed MT. Tromboseprofylaxe in de orthopedische chirurgie: de klinische praktijk in Nederland anno 2002. Ned Tijdschr Geneeskd 2003;147:1856-60.
2. McLean J. The thromboplastic action of cephalin. Am J Physiol 1916;47:328-41.
3. Howell WH, Holt E. Two new factors in blood coagulation-heparin and pro-antithrombin. Am J Physiol 1918;47:328-41.
4. Mason EC. A note on the use of heparin in blood transfusion. J Lab Clin Med 1924;10:203-6.
5. Hedenius P, Wilander O. The influence of intravenous injections of heparin in man on the time of coagulation. Acta Med Scand 1936; 88:443-9.
6. Crafoord C. Preliminary report on post-operative treatment with heparin as a prevention of thrombosis. Acta Chir Scand 1937;79: 407-26.
7. Murray DWG, Jaques LB, Perret TS, Best CH. Heparin and the thrombosis of veins following injury. Surgery 1937;2:163-87.
8. Kakkar VV, Corrigan TP, Fossard DP, Sutherland I, Thirwell J. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Lancet 1977;i:567-9.
9. Link KP. The anticoagulant from spoiled sweet clover hay. Harvey Lectures 1943;34:162-207.
10. Bingham JB, Meyer OO, Pohle FJ. Studies on the hemorrhagic agent 3,3′-methylene-bis-(4-hydroxycoumarin): its effects on the pro-thrombin and coagulation time of the blood of dogs and humans. Am J Med Sci 1941;202:563-78.
11. Nichol ES, Page SW. Dicoumarol therapy in acute coronary thrombosis: results of fifty attacks. J Fla Med Assoc 1946;32:365-70.
12. Allen EV, Barker NV, Waugh JM. A preparation from spoiled sweet clover. JAMA 1942;120:1009-15.
13. Link KP. The discovery of dicoumarin and its sequals. Circulation 1959;19:97-107.
14. Shapiro F. Warfarin sodium derivate (coumadin sodium): intravenous hypoprothrombinaemia inducing agent. Angiology 1953;4:380-90.
15. Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345:1305-10.
16. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001;345: 1298-304.
17. Lassen MR, Bauer KA, Eriksson BI, Turpie AG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002;359:1715-20.
18. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002;359:1721-6.
19. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002;162:1833-40.
20. Eriksson BI, Wille-Jorgensen P, Kalebo P, Mouret P, Rosencher N, Bosch P, et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997;337:1329-35.
21. Eriksson BI, Ekman S, Lindbratt S, Baur M, Bach D, Torholm C, et al. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement. J Bone Joint Surg [Am] 1997;79:326-33.
22. Eriksson BI, Ekman S, Kalebo P, Zachrisson B, Bach D, Close P. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996;347:635-9.
23. Ostendorf M, Johnell O, Malchau H, Dhert WJ, Schrijvers AJ, Verbout AJ. The epidemiology of total hip replacement in the Netherlands and Sweden. Acta Orthop Scand 2002;73:282-6.
24. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson jr FA, et al. Prevention of venous thromboembolism. Chest 2001; 119(1 Suppl):132S-75S.
25. Dechavanne M, Ville D, Berruyer M, Trepo F, Dalery F, Clermont N, et al. Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis 1989;19:5-12.
26. Levine MN, Hirsh J, Gent M, Turpie AG, Leclerc J, Powers PJ, et al. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 1991;114:545-51.
27. Leyvraz P, Bachmann F, Bohnet J, Breyer HG, Estoppey D, Haas SB, et al. Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid lomoparan and heparin-dihydroergotamine. Br J Surg 1992;79:911-4.
28. Planes A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, et al. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988;60:407-10.
29. Leclerc JR, Geerts WH, Desjardins L, Jobin F, Laroche F, Delorme F, et al. Prevention of deep vein thrombosis after major knee surgery - a randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 1992;67:417-23.
30. Dahl OE, Andreassen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, et al. Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997;77:26-31.
31. Eriksson BI, Kalebo P, Anthymyr BA, Wadenvik H, Tengborn L, Risberg B. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin. J Bone Joint Surg [Am] 1991;73:484-93.
32. Lotke PA, Ecker ML, Alavi A, Berkowitz H. Indications for the treatment of deep venous thrombosis following total knee replacement. J Bone Joint Surg [Am] 1984;66:202-8.
33. Stringer MD, Steadman CA, Hedges AR, Thomas EM, Morley TR, Kakkar VV. Deep vein thrombosis after elective knee surgery. J Bone Joint Surg [Br] 1989;71:492-7.
34. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplastics. J Bone Joint Surg [Am] 1984;66:194-201.
35. Douketis JD, Eikelboom JW, Quinlan DJ, Willan AP, Crowther MA. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002; 162:1465-71.
36. Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM. Prophylactic agents for venous thrombosis in elective hip surgery. Metaanalysis of studies using venographic assessment. Arch Intern Med 1993;153:2221-8.
37. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994;271:1780-5.
38. Freedman KB, Brookenthal KR, Fitzgerald jr RH, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg [Am] 2000; 82:929-38.
39. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988;318:1162-73
40. Collaborative overview of randomised trials of antiplatelet therapy - III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:235-46.
41. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin. Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-302.
42. Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, et al. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med 2001; 161:1952-60.
43. Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med 2002;162:1451-6.
44. Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 1999;159:137-41.
45. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med 1998;158:1525-31.
46. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001;358:9-15.
47. Prandoni P, Bruchi O, Sabbion P, Tanduo C, Scudeller A, Sardella C, et al. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Arch Intern Med 2002;162:1966-71.
48. Samama CM, Vray M, Barre J, Fiessinger JN, Rosencher N, Lecompte T, et al. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant. Arch Intern Med 2002;162: 2191-6.
49. Eriksson BI, Lassen MR. PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous tromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003;163:1337-42.
50. Haas SB, Insall JN, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg [Am] 1990;72:27-31.
51. Hull R, Delmore TJ, Hirsh J, Gent M, Armstrong P, Lofthouse R, et al. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res 1979;16:37-45.
52. McKenna R, Galante J, Bachmann F, Wallace DL, Kaushal PS, Meredith P. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J 1980;280:514-7.
53. Wilson NV, Das SK, Kakkar VV, Maurice HD, Smibert JG, Thomas EM, et al. Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V impulse system. J Bone Joint Surg [Br] 1992; 4:50-2.
54. Lassen MR, Borris LC, Christiansen HM, Boll KL, Eiskjaer SP, Nielsen BW, et al. Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo. Acta Orthop Scand 1991;62:33-8.
55. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg [Br] 1995; 77:6-10.
56. Samama CM, Clergue F, Barre J, Montefiore A, Ill P, Samii K. Low molecular weight heparin associated with spinal anaesthesia and gradual compression stockings in total hip replacement surgery. Arar Study Group. Br J Anaesth 1997;78:660-5.
57. Paiement G, Wessinger SJ, Waltman AC, Harris WH. Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty 1987;2:23-6.
58. Bailey JP, Kruger MP, Solano FX, Zajko AB, Rubash HE. Prospective randomized trial of sequential compression devices vs low-dose warfarin for deep venous thrombosis prophylaxis in total hip arthroplasty. J Arthroplasty 1991;6 Suppl:S29-35.
59. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg [Am] 1996;78:826-34.
60. Blanchard J, Meuwly JY, Leyvraz PF, Miron MJ, Bounameaux H, Hoffmeyer P, et al. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg [Br] 1999;81:654-9.
61. Fordyce MJ, Ling RS. A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg [Br] 1992;74:45-9.
62. Norgren L, Toksvig-Larsen S, Magyar G, Lindstrand A, Albrechtsson U. Prevention of deep vein thrombosis in knee arthroplasty. Preliminary results from a randomized controlled study of low molecular weight heparin vs foot pump compression. Int Angiol 1998;17:93-6.
63. Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg [Am] 1998;80:1158-66.
64. Hoppener MR, Ettema HB, Büller HR, Henny CP, Verheyen CCPM. Day-care or short-stay surgery and venous thromboembolism. J Thromb Haemost 2003;1:863-5.
65. Wirth T, Schneider B, Misselwitz F, Lomb M, Tuylu H, Egbring R, et al. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial. Arthroscopy 2001;17:393-9.